Company

UB Pharmaceutical

UB Pharmaceutical develops medicines and wellness products for pets and provides preclinical research services.

About

UB Pharmaceutical develops and distributes veterinary medicines and non-prescription pet health products. Its portfolio includes anti-inflammatory treatments, pain medication, dermatology products, dental care, skin mists, and acne kits; its CRO division provides preclinical and non-clinical services. Founded in 2019, the company is based in Seoul, South Korea. In July 2023, it raised KRW 1 billion in seed funding led by Atinum Ventures, with participation from FuturePlay.

1Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in